| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President and CEO
1 company
Christopher Richard Anzalone is Chief Executive Officer at ARWR. From March 2015 to January 2026, the filings on record show 0 open-market purchases and 37 sales. Christopher Richard Anzalone's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $225.8M at current prices.
Historically, Christopher Richard Anzalone's trades have earned a middling insider score of 60/100 across 27 rated trades. Over a 12-month horizon, 55.0% of those trades were profitable, with an average 12-month return of -24.1%.
The ARWR filings lean toward selling, a net 3,054,419 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 55,000 | $68.73 | $3,780,347.33 | -2.1% | |
| Oct 23, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $58.21 | $5,821,031.52 | -3.8% | |
| Aug 13, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 50,000 | $41.35 | $2,067,500.00 | -1.9% | |
| Jun 25, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $38.81 | $3,881,017.02 | -3.7% | |
| Dec 24, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 83,333 | $63.50 | $5,291,645.50 | -4.4% | |
| Dec 13, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 183,333 | $67.15 | $12,310,119.07 | -8.8% | |
| Dec 3, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 50,000 | $67.33 | $3,366,521.82 | -2.4% | |
| Oct 10, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 56,325 | $31.83 | $1,792,824.75 | -2.6% | |
| Sep 25, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 20,000 | $28.25 | $565,000.00 | -0.9% | |
| Sep 24, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 112,650 | $28.54 | $3,215,055.12 | -5.0% |